Rima Jubran

3.0k total citations · 1 hit paper
68 papers, 1.8k citations indexed

About

Rima Jubran is a scholar working on Ophthalmology, Surgery and Genetics. According to data from OpenAlex, Rima Jubran has authored 68 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Ophthalmology, 20 papers in Surgery and 16 papers in Genetics. Recurrent topics in Rima Jubran's work include Ocular Oncology and Treatments (41 papers), Glioma Diagnosis and Treatment (15 papers) and Head and Neck Surgical Oncology (12 papers). Rima Jubran is often cited by papers focused on Ocular Oncology and Treatments (41 papers), Glioma Diagnosis and Treatment (15 papers) and Head and Neck Surgical Oncology (12 papers). Rima Jubran collaborates with scholars based in United States, Argentina and Canada. Rima Jubran's co-authors include Jonathan W. Kim, Jesse L. Berry, A. Linn Murphree, Jonathan L. Finlay, Carlos Rodríguez‐Galindo, Araz Marachelian, Riccardo Haupt, R. Maarten Egeler, Jean Donadieu and Gritta Janka and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Clinical Infectious Diseases.

In The Last Decade

Rima Jubran

67 papers receiving 1.8k citations

Hit Papers

Langerhans cell histiocytosis (LCH): Guidelines for diagn... 2012 2026 2016 2021 2012 100 200 300

Peers

Rima Jubran
Constance A. Stanton United States
Saskia M. Imhof Netherlands
Suzanne K. Freitag United States
Kaan Gündüz Türkiye
Carol L. Shields United States
John J. Woog United States
H. Nida Sen United States
Rima Jubran
Citations per year, relative to Rima Jubran Rima Jubran (= 1×) peers Hayyam Kıratlı

Countries citing papers authored by Rima Jubran

Since Specialization
Citations

This map shows the geographic impact of Rima Jubran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rima Jubran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rima Jubran more than expected).

Fields of papers citing papers by Rima Jubran

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rima Jubran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rima Jubran. The network helps show where Rima Jubran may publish in the future.

Co-authorship network of co-authors of Rima Jubran

This figure shows the co-authorship network connecting the top 25 collaborators of Rima Jubran. A scholar is included among the top collaborators of Rima Jubran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rima Jubran. Rima Jubran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chintagumpala, Murali, Jin Piao, Dan S. Gombos, et al.. (2023). A multi‐institutional feasibility study of intra‐arterial chemotherapy in children with retinoblastoma. A Children's Oncology Group study (COG ARET12P1). Pediatric Blood & Cancer. 71(1). e30718–e30718. 4 indexed citations
3.
Xu, Liya, Ashley Polski, Rishvanth K. Prabakar, et al.. (2021). Establishing the Clinical Utility of ctDNA Analysis for Diagnosis, Prognosis, and Treatment Monitoring of Retinoblastoma: The Aqueous Humor Liquid Biopsy. Cancers. 13(6). 1282–1282. 42 indexed citations
4.
Xu, Liya, Ashley Polski, Rishvanth K. Prabakar, et al.. (2020). Chromosome 6p Amplification in Aqueous Humor Cell-Free DNA Is a Prognostic Biomarker for Retinoblastoma Ocular Survival. Molecular Cancer Research. 18(8). 1166–1175. 39 indexed citations
5.
Jubran, Rima, Judith G. Villablanca, Mark Krailo, et al.. (2020). A single‐arm study of systemic and sub‐Tenon chemotherapy for Groups C and D intraocular retinoblastoma: A Children's Oncology Group study (ARET 0231). Pediatric Blood & Cancer. 67(9). e28502–e28502. 4 indexed citations
6.
Berry, Jesse L., Maria Pefkianaki, Mark W. Reid, et al.. (2020). Intravitreal Melphalan for Retinoblastoma: The Impact of Toxicity on Recurrence and Ultimate Globe Salvage. Ocular Oncology and Pathology. 6(6). 388–394. 14 indexed citations
7.
Berry, Jesse L., Liya Xu, Irsan Kooi, et al.. (2018). Genomic cfDNA Analysis of Aqueous Humor in Retinoblastoma Predicts Eye Salvage: The Surrogate Tumor Biopsy for Retinoblastoma. Molecular Cancer Research. 16(11). 1701–1712. 85 indexed citations
8.
Berry, Jesse L., Ramon Lee, Luv Patel, et al.. (2018). Posterior Vitreous Detachment and the Associated Risk of Retinal Toxicity with Intravitreal Melphalan Treatment for Retinoblastoma. Ocular Oncology and Pathology. 5(4). 238–244. 4 indexed citations
9.
Berry, Jesse L., Sona Shah, Emily Zolfaghari, et al.. (2017). Not All Seeds Are Created Equal: Seed Classification Is Predictive of Outcomes in Retinoblastoma. Ophthalmology. 124(12). 1817–1825. 43 indexed citations
10.
Berry, Jesse L., et al.. (2017). Optic Nerve Obscuration in Retinoblastoma: A Risk Factor for Optic Nerve Invasion. Ocular Oncology and Pathology. 3(4). 283–291. 9 indexed citations
11.
Kim, Jonathan W., Hassan A. Aziz, Kathleen R. McGovern, et al.. (2017). Treatment Outcomes of Focal Laser Consolidation during Chemoreduction for Group B Retinoblastoma. Ophthalmology Retina. 1(5). 361–368. 4 indexed citations
12.
Berry, Jesse L., Rima Jubran, Kenneth Wong, et al.. (2014). Factors predictive of long-term visual outcomes of Group D eyes treated with chemoreduction and low-dose IMRT salvage: The Children's Hospital Los Angeles experience. British Journal of Ophthalmology. 98(8). 1061–1065. 9 indexed citations
13.
Tran, Hung C., Araz Marachelian, Rajkumar Venkatramani, Rima Jubran, & Leo Mascarenhas. (2014). Oxaliplatin and Doxorubicin for Relapsed or Refractory High-Risk Neuroblastoma. Pediatric Hematology and Oncology. 32(1). 26–31. 14 indexed citations
14.
Arkader, Alexandre, et al.. (2014). Outcomes of Children Younger Than 24 Months With Langerhans Cell Histiocytosis and Bone Involvement. Journal of Pediatric Orthopaedics. 34(8). 825–830. 4 indexed citations
15.
Haupt, Riccardo, Milen Minkov, Itziar Astigarraga, et al.. (2012). Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years. Pediatric Blood & Cancer. 60(2). 175–184. 372 indexed citations breakdown →
16.
Turkel, Susan Beckwitt, Mark D. Krieger, Sharon O’Neil, Rima Jubran, & C. Jane Tavaré. (2012). Symptoms before and after Posterior Fossa Surgery in Pediatric Patients. Pediatric Neurosurgery. 48(1). 21–25. 15 indexed citations
17.
Shane, Lisa, Ignacio Ferreira González, Floyd H. Gilles, et al.. (2011). Choroid plexus tumors; management, outcome, and association with the Li–Fraumeni syndrome: The Children's Hospital Los Angeles (CHLA) experience, 1991–2010. Pediatric Blood & Cancer. 58(6). 905–909. 52 indexed citations
18.
Dunkel, Ira J., Helen S. L. Chan, Rima Jubran, et al.. (2010). High‐dose chemotherapy with autologous hematopoietic stem cell rescue for stage 4B retinoblastoma. Pediatric Blood & Cancer. 55(1). 149–152. 52 indexed citations
19.
Butturini, Anna, Mary Jacob, Noam A. VanderWalde, et al.. (2009). High‐dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors. Cancer. 115(13). 2956–2963. 30 indexed citations
20.
Luban, Naomi L.C. & Rima Jubran. (2001). The Transfusion-Transmitted Viruses in Blood Transfusion. Advances in experimental medicine and biology. 489. 1–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026